Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry
- PMID: 33402443
- PMCID: PMC7786545
- DOI: 10.1136/rmdopen-2020-001505
Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry
Abstract
Aims: In Danish patients with inflammatory rheumatic diseases to explore self-protection strategies and health behaviour including adherence to disease-modifying antirheumatic treatment (DMARD) during the initial phase of the COVID-19 pandemic and again after the reopening of the society started. Furthermore, to identify characteristics of patients with high levels of anxiety and self-isolation.
Methods: Patients in routine care followed prospectively in the nationwide DANBIO registry were invited to answer an online questionnaire regarding disease activity and COVID-19 infection, behaviour in March and June 2020. Responses were linked to patient data in DANBIO. Characteristics potentially associated with anxiety, self-isolation and medication adherence (gender/age/diagnosis/education/work status/comorbidity/DMARD/smoking/EQ-5D/disease activity) were explored with multivariable logistic regression analyses.
Results: We included 12 789 patients (8168 rheumatoid arthritis/2068 psoriatic arthritis/1758 axial spondyloarthritis/795 other) of whom 65% were women and 36% treated with biological DMARD. Self-reported COVID-19 prevalence was 0.3%. Patients reported that they were worried to get COVID-19 infection (March/June: 70%/45%) and self-isolated more than others of the same age (48%/38%). The fraction of patients who changed medication due to fear of COVID-19 were 4.1%/0.6%. Female gender, comorbidities, not working, lower education, biological treatment and poor European Quality of life, 5 dimensions were associated with both anxiety and self-isolation.
Conclusion: In >12 000 patients with inflammatory arthritis, we found widespread anxiety and self-isolation, but high medication adherence, in the initial phase of the COVID-19 pandemic. This persisted during the gradual opening of society during the following months. Attention to patients' anxiety and self-isolation is important during this and potential future epidemics.
Keywords: arthritis; epidemiology; health care; outcome assessment; patient reported outcome measures; rheumatoid.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: Bente Glintborg: Research grants: AbbVie, BMS, Pfizer.Oliver Hendricks: Research grants: AbbVie, Novartis, Pfizer.Lene Terslev: Speakers fee: Speakers fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS and GE.Mikkel Østergaard: Research grants: Abbvie, BMS, Celgene, Merck, Novartis; Consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB.Rene Østgaard: Research grants: Abbvie; Consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi and UCB.Anne Gitte Loft: Consultancy and/or speakers fees: AbbVie, Eli-Lilly, Janssen, MSD, Novartis, Pfizer, and UCB.Merete Lund Hetland: AbbVie, Biogen, BMS, Celtrion, Eli Lilly Denmark A/S, Janssen Biologics B.V, Lundbeck Fonden, MSD, Pfizer, Roche, Samsung Biopis, Sandoz. MLH chairs the steering committee of the Danish Rheumatology Quality Registry (DANBIO), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH cochairs the EuroSpA research collaboration, which generates real-world evidence of treatment of psoriatic arthritis and axial spondyloarthritis based on secondary data and is partly funded by Novartis.Remaining authors: none declared.
Figures


Similar articles
-
Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.J Rheumatol. 2022 Oct;49(10):1163-1172. doi: 10.3899/jrheum.211280. Epub 2022 Jun 15. J Rheumatol. 2022. PMID: 35705237
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29. Ann Rheum Dis. 2020. PMID: 32471903 Free PMC article.
-
What is the true incidence of COVID-19 in patients with rheumatic diseases?Ann Rheum Dis. 2021 Feb;80(2):e18. doi: 10.1136/annrheumdis-2020-217615. Epub 2020 Apr 22. Ann Rheum Dis. 2021. PMID: 32321723 No abstract available.
-
DANBIO--powerful research database and electronic patient record.Rheumatology (Oxford). 2011 Jan;50(1):69-77. doi: 10.1093/rheumatology/keq309. Rheumatology (Oxford). 2011. PMID: 21148154 Review.
-
Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.Clin Rheumatol. 2023 Oct;42(10):2677-2690. doi: 10.1007/s10067-022-06486-4. Epub 2023 Jan 11. Clin Rheumatol. 2023. PMID: 36627529 Free PMC article. Review.
Cited by
-
The Danish Diabetes Musculoskeletal Cohort: Non-Responder Analysis of an Electronic Survey Using Registry Data.Clin Epidemiol. 2021 May 31;13:397-405. doi: 10.2147/CLEP.S293186. eCollection 2021. Clin Epidemiol. 2021. PMID: 34103998 Free PMC article.
-
Exploring the longer-term impact of the COVID-19 pandemic on physical and mental health of people with inflammatory rheumatic diseases: a cross-sectional survey.Clin Rheumatol. 2023 Jul;42(7):1903-1909. doi: 10.1007/s10067-023-06565-0. Epub 2023 Mar 7. Clin Rheumatol. 2023. PMID: 36882533 Free PMC article.
-
How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study.J Clin Rheumatol. 2024 Jan 1;30(1):e29-e33. doi: 10.1097/RHU.0000000000001882. Epub 2022 Jun 14. J Clin Rheumatol. 2024. PMID: 35699528 Free PMC article.
-
First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea.Lancet Rheumatol. 2021 Oct;3(10):e673-e675. doi: 10.1016/S2665-9913(21)00213-7. Epub 2021 Jun 18. Lancet Rheumatol. 2021. PMID: 34179833 Free PMC article. No abstract available.
-
Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark.J Clin Med. 2021 Aug 27;10(17):3842. doi: 10.3390/jcm10173842. J Clin Med. 2021. PMID: 34501290 Free PMC article.
References
-
- University and Medicine. Hopkins J. Coronavirus resource center. Available: https://coronavirus.jhu.edu/map.html [Accessed Oct 2020].
-
- Moiseev S, Avdeev S, Brovko M. Rheumatic diseases in intensive care unit patients with COVID-19. Ann Rheum Dis 2020. (Epub ahead of print: Oct 2020). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical